Breaking News

Readout of Secretary of Defense Lloyd J. Austin III’s Visit to Latvia > U.S. Department of Defense > Release Eight Municipalities Receive Multimillion Dollar Assignment for Safe Rooms Against Hurricanes Alabama Media Portal 2.0 – Press Releases Crew Member Visa Overstay Caught in New Orleans Readout of CSAF’s visit to Singapore > Air Force > Article Display US Department of Labor orders Louisiana helicopter ambulance service to reinstate Utah pilot who refused to fly in hazardous conditions CBP Officers Seize Fentanyl at the Ysleta Port of Entry Audio: This Date in Missouri Senate History for Aug. 10
Albuquerque, NM - Attorney General Hector Balderas and 41 other attorneys general yesterday filed an amended antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices. Reckitt Benckiser Pharmaceuticals, now known as Indivior, is accused of conspiring with MonoSol Rx to switch Suboxone from a tablet version to a film (that dissolves in the mouth) in order to prevent or delay generic alternatives and maintain monopoly profits.

Source link